Assessment of Factors Important in Atherosclerotic Occlusion and Restenosis

• References

• 1 Essed CD, Brand MV D, Becker AE. Transluminal coronary angioplasty and early restenosis. Br Heart J 1983; 49: 393-396
• 2 Austin GE, Ratliff NB, Hollman J, Tabei S, Phillips DF. Intimal proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 1985; 6: 369-375
• 3 Waller BF, Pinkerton CA, Foster LN. Morphologic evidence of accelerated left main coronary artery stenosis: A late complication of percutaneous transluminal balloon angioplasty of the proximal left anterior descending coronary arteiy. J Am Coll Cardiol 1987; 9: 1019-1023
• 4 Liu MW, Roubin GS, King SB. Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia. Circulation 1989; 79: 1374-1387
• 5 Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-813
• 6 Ross R. The pathogenesis of atherosclersis – an update. N Engl J Med 1986; 314: 488-500
• 7 Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990; 87: 4600-4604
• 8 MERCATOR Study Group. Does the new angiotensin-converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty. Circulation 1992; 86: 100-110
• 9 Folkow B. Physiological aspects of primary hypertension. Physiol Rev 1982; 62: 347-504
• 10 Jamal A, Bendeck M, Langille BL. Structural changes and recovery of function after arterial injury. Arteriosclerosis Thrombosis 1992; 12: 307-317
• 11 Langille BL, O’Donnell F. Reductions in arterial diameter produced by chronic diseases in blood flow are endothelium-dependent. Science 1986; 231: 405-407
• 12 Haudenschild CC, Schwartz SM. Endothelial regeneration. II. Restitution of endothelial continuity Lab Invest 1979; 41: 407-418
• 13 Barger AC, Beeuwkes RI, Lainey LL, Silverman KJ. Vasa vasorum and neovascularization of human coronary arteries. N Engl J Med 1984; 310: 175-177
• 14 Glagov S, Weisenberg E, Zarins CK, Stankunavicius R, Kolettis GJ. Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987; 316: 1371-1375
• 15 O’Malley MK, McDermott EW M, Mehigan D, O’Higgins NJ. Role for prazosin in reducing the development of rabbit intimal hyperplasia after endothelial denudation. Br J Surg 1989; 76: 936-938
• 16 Clowes AW, Reidy MA, Clowes MM. Mechanisms of stenosis after arterial injury. Lab Invest 1983; 49: 208-215
• 17 Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium Lab Invest 1983; 49: 327-333
• 18 Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J, Gent M, Tiell ML, Spaet TH. The effect of thrombocytopenia on experimental athersoclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization J Clin Invest 1977; 60: 1191-1201
• 19 Bjorkerud S, Bondjers G. Arterial repair and atherosclerosis after mechanical injury. Part 5. Tissue response after induction of a large superficial transverse injury Atherosclerosis 1973; 18: 235-255
• 20 Schwartz SM, Stemerman MB, Benditt EP. The aortic intima. II. Repair of the aortic lining after mechanical denudation Am J Pathol 1975; 81: 15-42
• 21 Betz E, Schlote W. Response of vessel walls to chronically applied electrical stimuli. Basic Res Cardiol 1979; 74: 10-20
• 22 French JE. Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to the endothelium. Int Rev Exp Pathol 1966; 5: 253-354
• 23 Baumgartner HR. Eine neue Methode zur Erzeugung der Thromben durch gezielte Uberdehnung der Gefasswand. Z Ges Exp Med 1963; 137: 227
• 24 Stemerman MB, Spaet TH, Pitlick F, Clintron J, Lejneks I, Tiell ML. Intimal healing: The pattern of reendothelialization and intimal thickening. Am J Pathol 1972; 87: 125
• 25 Clowes AW, Clowes MM, Lingerie J, Reidy MA. Kinetics of cellular proliferation after arterial injury. V. Role of acute distension in the induction of smooth muscle proliferation Lab Invest 1989; 60: 360-364
• 26 Clowes AW, Reidy MA. Prevention of stenosis aftervascular reconstruction: Pharmacologic control of intimal hyperplasia - A review. J Vasc Surg 1991; 13: 885-891
• 27 Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci USA 1989; 86: 8412-8416
• 28 Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992; 89: 507-511
• 29 Jackson CL, Raines E, Ross R, Reidy MA. Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury. Arteriosclerosis 1993; 13: 1218-1226
• 30 Ferns GA A, Raines EW, Spragel KH, Motani AS, Reidy MA, Ross R. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody to PDGF. Science 1991; 253: 1129-1132
• 31 Clowes AW, Clowes MM, Reidy MA. Kinetics of cellular proliferation after arterial injury. III. Endothelial and smooth muscle growth in chronically denuded vessels Lab Invest 1986; 54: 295-303
• 32 Olson NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor Am J Pathol 1992; 140: 1017-1023
• 33 Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy MA. Production of transforming growth factor-1 during repair of arterial injury. J Clin Invest 1991; 88: 904-910
• 34 Daemen MJ A P, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured arterial wall. Circ Res 1991; 68: 450-456
• 35 Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991; 88: 3739-3743
• 36 Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-113
• 37 Majesky MW, Giachelli CM, Schwartz SM. Rat carotid neointimal smooth muscle cells re-express a developmentally regulated phenotype during repair of arterial injury. Circ Res 1992; 71: 759-768
• 38 Giachelli CM, Bae N, Almeida M, Denhardt DT, Alpers CE, Schwartz SM. Osteopontin is elevated during neointima formation in rat arteries and is a novel component of human atherosclerotic plaques. J Clin Invest 1993; 92: 1686-1696
• 39 Fingerle J, Au YP, Clowes AW, Reidy MA. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 1990; 10: 1082-1087
• 40 Fawcett JW, Housden E. The effects of protease inhibitors on axon growth through astrocytes. Development 1990; 109: 59-66
• 41 Lindner V, Olson NE, Clowes AW, Reidy MA. Inhibition of smooth muscle cell proliferation in injured rat arteries. Interaction of heparin with basic fibroblast growth factor J Clin Invest 1992; 90: 2044-2049
• 42 Morishita R, Gibpns GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Single intraluminal delivery of antisense cdc2 kinase and proliferating cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993; 90: 8474-8478
• 43 Simons M, Edelman ER, Rosenberg RD. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J Clin Invest 1994; 93: 2351-2356
• 44 Bennett MR, Schwartz SM. Antisense therapy for angioplasty restenosis: Some critical considerations. Circulation. 1995 (in press)
• 45 Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRN A detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988; 82: 1134-1143
• 46 Schwartz SM, Foy L, Bowen-Pope DF, Ross R. Derivation and properties of platelet-derived growth factor-independent rat smooth muscle cells. Am J Pathol 1990; 136: 1417-1428
• 47 Majesky MW, Reidy MA, Bowen-Pope DF, Wilcox JN, Schwartz SM. Platelet-derived growth factor (PDGF) ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990; 111: 2149-2158
• 48 Roberts AB, Spom MB. Physiological actions and clinical applications of transforming growth factor- (TGF-). Am J Physiol 1993; 264: G179-G186
• 49 Pompili VJ, Shum L, Yang ZY, San H, Liptay S, Gordon D, Derynck R, Nabel GJ, Nabel EG. Direct gene transfer of transforming growth factor—1 in the arterial wall stimulates fibrocellular hyperplasia. Circulation 1993; 88 (4, Part 2) I468
• 50 Majack RA, Majesky MW, Goodman LV. Role of PDGF-A expression in the control of vascular smooth muscle cell growth by transforming growth factor-. J Cell Biol 1990; 111: 239-247
• 51 Battegay E, Raines E, Seifert RA, Bowen-Pope DF, Ross R. TGF-BB induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop. Cell 1990; 63: 515-524
• 52 Gibbons G, Pratt R, Dzau V. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine TGF-BB-1 expression determines growth response to angiotensin II J Clin Invest 1992; 90: 456-461
• 53 Heam JA, Donohue BC, Ba’albaki H, Douglas JS, King SB I, Lembo NJ, Roubin GS, Sgoutas DS. Usefulness of serum lipoprotein(a) as a predictor of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1992; 70: 1514
• 54 Grainger DJ, Kirschenlohr HL, Metcalfe JC, Weissberg PL. Proliferation of human smooth muscle cells promoted by lipoprotein(a). Science 1993; 260: 1655-1658
• 55 Wolf YG, Rasmussen LM, Ruoslahti E. Antibodies against transforming growth factor-1 suppress intimal hyperplasia in a rat model. J Clin Invest 1994; 93: 1172-1178
• 56 Jackson CL, Reidy MA. Basic fibroblast growth factor: Its role in the control of smooth muscle cell migration. Am J Pathol 1993; 143: 1024-1031
• 57 Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 1994; 75: 539-545
• 58 Block PC, Myler RK, Stertzer S, Fallon JT. Morphology after transluminal angioplasty in human beings. New Engl J Med 1981; 305: 382-385
• 59 Clowes AW, Clowes M, Kirkman T, Jackson C, Au Y, Kenagy R. Heparin inhibits the expression of tissue-type plasminogen activator by smooth muscle cells in injured rat carotid artery. Circ Res 1992; 70: 1128-1136
• 60 Clowes AW, Kamovsky MJ. Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 1977; 265: 625-626
• 61 Fischell TA, Grant G, Johnson DE. Determinants of smooth muscle injury during balloon angioplasty. Circulation 1990; 82: 2170-2184
• 62 Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 1994; 75: 181-189
• 63 Newman KM, Ogata Y, Malon AM, Irizarry E, Gandhi RH, Nagase H, Tilson MD. Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm. Arterioscler Thromb 1994; 14: 1315-1320
• 64 Newman KM, Malon AM, Shin RD, Scholes JV, Ramey WG, Tilson MD. Matrix metalloproteinases in abdominal aortic aneurysm: Characterization, purification, and their possible sources. Connect Tissue Res 1994; 30: 265-276
• 65 Giachelli CM, Majesky MW, Schwartz SM. Developmentally regulated cytochrome P450IA1 expression in cultured rat vascular smooth muscle cells. J Biol Chem 1991; 266: 3981-3986
• 66 Lemire JM, Covin CW, White S, Giachelli CM, Schwartz SM. Characterization of cloned aortic smooth muscle cells from young rats. Am J Pathol 1994; 144: 1068-1081
• 67 Walker LN, Bowen-Pope DF, Ross R, Reidy MA. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. Proc Natl Acad Sci USA 1986; 83: 7311-7315
• 68 Seifert RA, Schwartz SM, Bowen-Pope DF. Developmentally regulated production of platelet-derived growth factor-like molecules. Nature 1984; 311: 669-671
• 69 Lindner V, Giachelli CM, Schwartz SM, Reidy MA. A subpopulation of smooth muscle cells in rat arteries express PDGF-B chain mRNA. Circ Res. 1995 (in press)
• 70 Schwartz RS, Edwards WD, Huber KC, Antoniades LC, Bailey KR, Camrud AR, Jorgenson MA, Holmes DR. Coronary restenosis: Prospects for solution and new perspectives from a porcine model. Mayo Clin Proc 1993; 68: 54-62
• 71 Hatton MW, Moar SL, Richardson M. De-endothelialization in vivo initiates a thrombogenic reaction at the rabbit aorta surface. Am J Pathol 1989; 135: 499-508
• 72 Reidy MA. Proliferation of smooth muscle cells at sites distant from vascular injury. Arteriosclerosis 1990; 10: 298-305
• 73 Okazaki H, Majesky MW, Harker LA, Schwartz SM. Regulation of platelet-derived growth factor ligand and receptor gene expression by -thrombin in vascular smooth muscle cells. Circ Res 1992; 71: 1285-1293
• 74 Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Malden LT, Masuko H, Sato H. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990; 248: 1009-1012
• 75 Camey DH, Mann R, Redin WR, Pemia SD, Berry D, Heggers JP, Hayward PG, Robson MC, Christie J, Annable C, Fenton JW I, Glenn KC. Enhancement of incisional wound healing and neovascularization in normal rats by thrombin and synthetic thrombin receptor-activating peptides. J Clin Invest 1992; 89: 1469-1477
• 76 Bar-Shavit R, Benezra M, Eldor A, Hy-Am E, Fenton JW I, Wilner GD. Thrombin immobilized to extracellular matrix is a potent mitogen for vascular smooth muscle cells: Nonenzymaticmode of action. Cell Regulation 1990; 1: 453-463
• 77 Lam JY T, Chesebro JH, Steele PM, Heras M, Webster MW I, Badimon L, Fuster V. Antithrombotic therapy for deep arterial injury by angioplasty: Efficacy of common platelet inhibition compared with thrombin inhibition in pigs. Circulation 1991; 84: 814-820
• 78 Williams JK, Armstrong ML, Heistad DD. Vasa vasorum in atherosclerotic coronary arteries: Responses to vasoactive stimuli and regression of atherosclerosis. Circ Res 1988; 62: 515-523
• 79 deBlois D, Drapeau G, Petitclerc E, Marceau F. Synergism between contractile effect of epidermal growth factor and that of des-Arg⁹-bradykinin or of -thrombin in rabbit aortic rings. Br J Pharmacol 1992; 105: 959-967
• 80 Powell J, Clozel J, Muller R, Kuhn H, Hefti F, Hosang M, Baumgartner H. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989; 245: 186-188
• 81 Kauffman RF, Bean JS, Zimmerman KM, Brown RF, Steinberg MI. Losartan, a nonpeptide All receptor antagonist, inhibits neointima formation following balloon injury to rat carotid arteries. Life Sci 1991; 49: PL223-PL228
• 82 Prescott M, Webb R, Reidy MA. Angiotensin-converting enzyme inhibitors versus angiotensin II, ATI receptor antagonist: Effects cm smooth muscle cell migration and proliferation after balloon catheter injury. Am J Pathol 1991; 139: 1291-1302
• 83 Farhy RD, Ho KL, Carretero OA, Scicli AG. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 1992; 182: 283-288
• 84 Huber KC, Schwartz RS, Edwards WD, Camrud AR, Bailey KR, Jorgenson MA, Holmes DR. Effects of angiotensin converting enzyme inhibition on neointimal proliferation in a porcine coronary injury model. Am Heart J 1993; 125: 695-701
• 85 Griffin S, Brown W, MacPherson F, McGrath J, Wilson V, Korsgaard N, Mulvany M, Lever A. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991; 17: 626-635
• 86 Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988; 62: 749-756
• 87 Poulsen K, Jacobsen J. Enzymic reactions of the renin-angiotensin system. In: Robertson JI, Nicholls MG. eds. The Renin-Angiotensin System. Vol.I New York, NY: Gower Medical Publishing; 1993: 5.1-5.12
• 88 Rakugi H, Krieger J, Wang DS, Dzau VJ, Pratt RE. Induction of angiotensin-converting enzyme in neointima after balloon injury. Arteriosclerosis Thrombosis 1991; 11: 1396a
• 89 Viswanathan M, Stromberg C, Seltzer A, Saavedra JM. Balloon angioplasty enhances the expression of angiotensin II ATI receptors in neointima of rat aorta. J Clin Invest 1992; 90: 1707-1712
• 90 Fishel RS, Redden RA, Bernstein KE, Berk BC. Angiotensin-converting enzyme and vascular injury: Synergistic upregulation by stress steroids and basic fibroblast growth factor. Circulation 1992; 86 (01) I85
• 91 Bell L, Madri JA. Influence of the angiotensin system cm endothelial and smooth muscle cell migration. Am J Pathol 1990; 137: 7-12
• 92 Powell JS, Muller RK M, Rouge M, Kuhn H, Hefti F, Baumgartner HR. The proliferative response to vascular injury is suppressed by angiotensin-converting enzyme inhibition. J Cardiovasc Pharmacol 1990; 16 (04) S42-S49
• 93 Kaartinen M, Penttila A, Kovanen PT. Mast cells of the two types differing in neutral protease composition in the human aortic intima. Demonstration of trypase- and trypase/chymase-containing mast cells in normal intimas, fatty streaks and the shoulder region of atheromas Arterioscler Thromb 1994; 14: 966-972
• 94 Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, Yokoi H, Kim K. Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol 1991; 17: 433-439
• 95 Miller MJ, Kuntz RE, Friedrich SP, Leidig GA, Fishman RF, Schnitt SJ, Bairn DS, Safian RD. Frequency and consequences of intimal hyperplasia in specimens retrieved by directional atherectomy of native primary coronary artery stenoses and subsequent restenoses. Am J Cardiol 1993; 71: 652-658
• 96 Schnitt SJ, Safian RD, Kuntz RE, Schmidt DA, Bairn DS. Histologic findings in specimens obtained by percutaneous directional coronary atherectomy. Hum Pathol 1992; 23: 415-420
• 97 Orekhov AN, Ankarpova II, Tertov VV, Rudchenko SA, Addreeva ER, Krushinsky AV, Smirnov RN. Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima: light-microscopic study of dissociated aortic cells. Am J Pathol 1984; 115: 17-24
• 98 Andreeva ER, Rekhter MD, Romanov YA, Antonova GM, Antonov AS, Mironov AA, Orekhov AN. Stellate cells of aortic intima: II. Arborization of intimal cells in culture. Tissue Cell 1992; 24: 697-704
• 99 O’Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, Benditt EP, Hinohara T, Simpson JB, Schwartz SM. Proliferation in primary and restenotic coronary atherectomy tissue; Implications for antiproliferative therapy. Circ Res 1993; 73: 223-231
• 100 Leclerc G, Kearney M, Schneider D, Rosenfield K, Losordo DW, Isner JM. Assessment of cell kinetics in human restenotic lesions by in vitro bromodeoxyuridine labeling of excised atherectomy specimens. clin Res 1993; 41: 343A
• 101 Strauss BH, Umans VA, VanSuylen RJ, deFeyter PJ, Marco J, Robertson GC, Renkin J, Heyndrickx G, Vuzevski VD, Bosnian FT. Directional atherectomy for treatment of restenosis within coronary stents: Clinical, angiographic and histological results. J Am Coll Cardiol 1992; 20: 1465-1473
• 102 Pickering JG, Weir L, Jekanowski J, Kearney MA, Isner JM. Proliferative activity in peripheral and coronary atherosclerotic plaque among patients undergoing percutaneous revascularization. J Clin Invest 1993; 91: 1469-1480
• 103 Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA/cycin monoclonal antibodies in fixed, embedded tissues: Comparison with flow cytometric analysis. Am J Pathol 1989; 134: 733-739
• 104 Spagnoli LG, Villaschi S, Neri L, Palmieri G, Taurino M, Faraglia V, Fiorani P. Autoradiographic studies of the smooth muscle cells in human arteries. Arterial Wall 1981; 7: 107-112
• 105 Rekhter M, Nicholls S, Ferguson M, Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arterioscler Thromb 1993; 13: 609-617
• 106 Mintz GS, Douek PC, Bonner RF, Kent KM, Pichard AD, Satler LF, Leon MB. Intravascularultrasound comparison of de novo and restenotic coronary artery lesions. J Am Coll Cardiol 1993; 21: 118A
• 107 Lesperance J, Bourassa MG, Schwartz L, Hudon G, Laurier J, Eastwood C, Kazim F. Definition and measurement of restenosis after successful coronary angioplasty: Implications for clinical trials. Am Heart J 1993; 125: 1394-1408
• 108 Kuntz RE, Gibson M, Nobuyoshi M, Bairn DS. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 1993; 21: 15-25
• 109 Penny WF, Schmidt DA, Safian RD, Emy RE, Bairn DS. Insights into the mechanism ofluminal improvement after directional coronary atherectomy. Am J Cardiol 1991; 67: 435-437
• 110 Faxon DP, Weber VJ, Haudenschild C, Gottsman SB, McGovern WA, Ryan TJ. Acute effects of angioplasty in three experimental models of atherosclerosis. Arteriosclerosis 1982; 2: 125-133
• 111 Sanborn TA, Faxon DP, Haudenschild C, Gottsman SB, Ryan TJ. The mechanism of transluminal angioplasty: Evidence for formation of aneurysms in experimental atherosclerosis. Circulation 1983; 68: 1136-1140
• 112 Fischell TA, Derby G, Tse TM, Stadius ML. Coronary artery vasoconstriction routinely occurs after percutaneous transluminal coronary angioplasty: a quantitative arteriographic analysis. Circulation 1988; 78: 1323-1334
• 113 Nobuyoshi M, Kimura H, Nosaka H, Mioka S, Ueno K, Hamasaki N, Horiuchi H, Oshishi H. Restenosis after successfulpercutaneous transluminal coronary angioplasty: Serial angiographic follow-up of 299 patients. J Am Coll Cardiol 1988; 12: 616-623
• 114 Isner JM, Rosenfield K, Losordo DW, Rose L, Langevin RE J, Razvi S, Kosowsky BD. Combination balloon-ultrasound imaging catheter for percutaneous transluminal angioplasty. Validation of imaging, analysis of recoil, and identification of plaque fracture Circulation 1991; 84: 739-754